David Wang1, Amanda J Piper1, Brendon J Yee2, Keith K Wong2, Jong-Won Kim3, Angela D'Rozario4, Luke Rowsell5, Derk-Jan Dijk6, Ronald R Grunstein2. 1. Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Sydney, Australia (work performed) ; Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia. 2. Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Sydney, Australia (work performed) ; Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia ; Centre for Integrated Research and Understanding of Sleep (CIRUS), University of Sydney, Sydney, Australia. 3. Centre for Integrated Research and Understanding of Sleep (CIRUS), University of Sydney, Sydney, Australia ; School of Physics, University of Sydney, Sydney, Australia. 4. Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia ; Centre for Integrated Research and Understanding of Sleep (CIRUS), University of Sydney, Sydney, Australia. 5. Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia. 6. Surrey Sleep Research Centre, University of Surrey, UK.
Abstract
BACKGROUND: The key determinants of daytime drowsiness in sleep disordered breathing (SDB) are unclear. Hypercapnia has not been examined as a potential contributor due to the lack of reliable measurement during sleep. To overcome this limitation, we studied predominantly hypercapnic SDB patients to investigate the role of hypercapnia on EEG activation and daytime sleepiness. METHODS: We measured overnight polysomnography (PSG), arterial blood gases, and Epworth Sleepiness Scale in 55 severe SDB patients with obesity hypoventilation syndrome or overlap syndrome (COPD+ obstructive sleep apnea) before and ∼3 months after positive airway pressure (PAP) treatment. Quantitative EEG analyses were performed, and the Delta/ Alpha ratio was used as an indicator of EEG activation. RESULTS: After the PAP treatment, these patients showed a significant decrease in their waking pCO(2), daytime sleepiness, as well as all key breathing/oxygenation parameters during sleep. Overnight Delta/Alpha ratio of EEG was significantly reduced. There is a significant cross-correlation between a reduced wake pCO(2), a faster (more activated) sleep EEG (reduced Delta/Alpha ratio) and reduced daytime sleepiness (all p < 0.05) with PAP treatment. Multiple regression analyses showed the degree of change in hypercapnia to be the only significant predictor for both ESS and Delta/ Alpha ratio. CONCLUSIONS: Hypercapnia is a key correlate of EEG activation and daytime sleepiness in hypercapnic SDB patients. The relationship between hypercapnia and sleepiness may be mediated by reduced neuro-electrical brain activity.
BACKGROUND: The key determinants of daytime drowsiness in sleep disordered breathing (SDB) are unclear. Hypercapnia has not been examined as a potential contributor due to the lack of reliable measurement during sleep. To overcome this limitation, we studied predominantly hypercapnic SDB patients to investigate the role of hypercapnia on EEG activation and daytime sleepiness. METHODS: We measured overnight polysomnography (PSG), arterial blood gases, and Epworth Sleepiness Scale in 55 severe SDB patients with obesity hypoventilation syndrome or overlap syndrome (COPD+ obstructive sleep apnea) before and ∼3 months after positive airway pressure (PAP) treatment. Quantitative EEG analyses were performed, and the Delta/ Alpha ratio was used as an indicator of EEG activation. RESULTS: After the PAP treatment, these patients showed a significant decrease in their waking pCO(2), daytime sleepiness, as well as all key breathing/oxygenation parameters during sleep. Overnight Delta/Alpha ratio of EEG was significantly reduced. There is a significant cross-correlation between a reduced wake pCO(2), a faster (more activated) sleep EEG (reduced Delta/Alpha ratio) and reduced daytime sleepiness (all p < 0.05) with PAP treatment. Multiple regression analyses showed the degree of change in hypercapnia to be the only significant predictor for both ESS and Delta/ Alpha ratio. CONCLUSIONS:Hypercapnia is a key correlate of EEG activation and daytime sleepiness in hypercapnic SDBpatients. The relationship between hypercapnia and sleepiness may be mediated by reduced neuro-electrical brain activity.
Authors: Stuart F Quan; Cynthia S Chan; William C Dement; Alan Gevins; James L Goodwin; Daniel J Gottlieb; Sylvan Green; Christian Guilleminault; Max Hirshkowitz; Pamela R Hyde; Gary G Kay; Eileen B Leary; Deborah A Nichols; Paula K Schweitzer; Richard D Simon; James K Walsh; Clete A Kushida Journal: Sleep Date: 2011-03-01 Impact factor: 5.849
Authors: M Olaithe; P R Eastwood; R S Bucks; Naomi L Deacon; Atul Malhotra; Vasantha H S Kumar; Li Zuo; Chia-Chen Chuang; Helena Schotland Journal: J Appl Physiol (1985) Date: 2016-06-15
Authors: Ahmad Tamimi; Said Dahbour; Assma Al-Btush; Abdelkarim Al-Qudah; Amira Masri; Subhi Al-Ghanem; Malik E Juweid; Yazan Olaimat; Amer Al Qaisi; Qutada Al-Soub; Maha Naim; Ali Sawalmeh; Rund Jarrar; Tala Tarawneh; Mai Bader; Iskandar Tamimi Journal: Sci Rep Date: 2022-05-31 Impact factor: 4.996
Authors: Magdy K Younes; Andrew E Beaudin; Jill K Raneri; Beth J Gerardy; Patrick J Hanly Journal: J Clin Sleep Med Date: 2022-08-01 Impact factor: 4.324
Authors: Anna E Mullins; Korey Kam; Ankit Parekh; Omonigho M Bubu; Ricardo S Osorio; Andrew W Varga Journal: Neurobiol Dis Date: 2020-08-27 Impact factor: 5.996
Authors: David Wang; Xiao Xue Bai; Shaun C Williams; Shu Cheng Hua; Jong-Won Kim; Nathaniel S Marshall; Angela D'Rozario; Ronald R Grunstein Journal: Sleep Date: 2015-08-01 Impact factor: 5.849
Authors: Andrew E Beaudin; Jill K Raneri; Najib T Ayas; Robert P Skomro; Eric E Smith; Patrick J Hanly Journal: J Clin Sleep Med Date: 2022-01-01 Impact factor: 4.062